A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: A potential marker of physical activity

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Parker, Tony J ^a   Sampson, Dayle L ^a   Broszczak, Daniel ^a   Chng, Yee L ^a   Carter, Shea L ^a   Leavesley, David I ^a   Parker, Anthony W ^a   Upton, Zee ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOREPELLIN; HYDROCORTISONE; PEPTIDE; PEPTIDE LG3; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UREA; ENDOREPELLIN PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEOHEPARAN SULFATE;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRIVER; HUMAN; MALE; MINER; OCCUPATIONAL ACCIDENT; PHYSICAL ACTIVITY; PROTEIN URINE LEVEL; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; WORK SCHEDULE; CHEMISTRY; MASS SPECTROMETRY; MIDDLE AGED; MINING; MOTOR ACTIVITY; OCCUPATIONAL EXPOSURE; POLYACRYLAMIDE GEL ELECTROPHORESIS; URINE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MINING; MOTOR ACTIVITY; OCCUPATIONAL EXPOSURE; PEPTIDE FRAGMENTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84858771289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033714     Document Type: Article

References (69)

1. Burdorf A, Sorock G, (1997) Positive and negative evidence of risk factors for back disorders. Scand J Work Environ Health 23: 243-256.
2. Choi WJ, Kang YJ, Kim JY, Han SH, (2009) Symptom prevalence of musculoskeletal disorders and the effects of prior acute injury among aging male steelworkers. J Occup Health 51: 273-282.
3. Punnett L, Wegman DH, (2004) Work-related musculoskeletal disorders: the epidemiologic evidence and the debate. J Electromyogr Kinesiol 14: 13-23.
4. O'Kane JW, Hutchinson E, Atley LM, Eyre DR, (2006) Sport-related differences in biomarkers of bone resorption and cartilage degradation in endurance athletes. Osteoarthritis Cartilage 14: 71-76.
5. Lac G, Berthon P, (2000) Changes in cortisol and testosterone levels and T/C ratio during an endurance competition and recovery. J Sports Med Phys Fitness 40: 139-144.
6. Lac G, Maso F, (2004) Biological markers for the follow-up of athletes throughout the training season. Pathol Biol (Paris) 52: 43-49.
7. Langberg H, Skovgaard D, Asp S, Kjaer M, (2000) Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcif Tissue Int 67: 41-44.
8. Gleeson M, (2002) Biochemical and immunological markers of over-training. Journal of Sports Science & Medicine 1: 31-41.
9. Rowbottom DG, Keast D, Garcia-Webb P, Morton AR, (1997) Training adaptation and biological changes among well-trained male triathletes. Med Sci Sports Exerc 29: 1233-1239.
10. Derman W, Schwellnus MP, Lambert MI, Emms M, Sinclair-Smith C, et al. (1997) The 'worn-out athlete': a clinical approach to chronic fatigue in athletes. J Sports Sci 15: 341-351.
11. Sevier TL, Wilson JK, Helfst B, (2000) The industrial athlete? Work 15: 203-207.
12. Ball D, Herrington L, (1998) Training and overload: adaptation and failure in the musculoskeletal system. Journal of Bodywork and Movement Therapies pp. 161-167.
13. Newham DJ, Jones DA, Clarkson PM, (1987) Repeated high-force eccentric exercise: effects on muscle pain and damage. J Appl Physiol 63: 1381-1386.
14. Kjaer M, (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84: 649-698.
15. Paulsen G, Crameri R, Benestad HB, Fjeld JG, Morkrid L, et al. (2010) Time course of leukocyte accumulation in human muscle after eccentric exercise. Med Sci Sports Exerc 42: 75-85.
16. Purvis D, Gonsalves S, Deuster PA, (2010) Physiological and psychological fatigue in extreme conditions: overtraining and elite athletes. PM R 2: 442-450.
17. Garde AH, Faber A, Persson R, Hansen AM, Hjortskov N, et al. (2007) Concentrations of cortisol, testosterone and glycosylated haemoglobin (HbA1c) among construction workers with 12-h workdays and extended workweeks. Int Arch Occup Environ Health 80: 404-411.
18. Hennig J, Kieferdorf P, Moritz C, Huwe S, Netter P, (1998) Changes in cortisol secretion during shiftwork: implications for tolerance to shiftwork? Ergonomics 41: 610-621.
19. Petibois C, Cazorla G, Poortmans JR, Deleris G, (2002) Biochemical aspects of overtraining in endurance sports: a review. Sports Med 32: 867-878.
20. Urhausen A, Kindermann W, (2002) Diagnosis of overtraining: what tools do we have? Sports Med 32: 95-102.
21. GW Jr, Cazares LH, Leung SM, Nasim S, Adam BL, et al. (1999) Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 2: 264-276.
22. Tolson J, Bogumil R, Brunst E, Beck H, Elsner R, et al. (2004) Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 84: 845-856.
23. Cieniewski-Bernard C, Acosta A, Dubois E, Lamblin N, Beseme O, et al. (2008) Proteomic analysis in cardiovascular diseases. Clin Exp Pharmacol Physiol 35: 362-366.
24. Meilhac O, Delbosc S, Michel JB, (2007) Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry. Methods Mol Biol 357: 331-341.
25. Vanhoutte KJ, Laarakkers C, Marchiori E, Pickkers P, Wetzels JF, et al. (2007) Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools. Nephrol Dial Transplant 22: 2932-2943.
26. Papale M, Pedicillo MC, Thatcher BJ, Di Paolo S, Muzio LL, et al. (2007) Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis. J Chromatogr B Analyt Technol Biomed Life Sci.
27. Roelofsen H, Alvarez-Llamas G, Schepers M, Landman K, Vonk RJ, (2007) Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry. Proteome Sci 5: 2.
28. Ward DG, Nyangoma S, Joy H, Hamilton E, Wei W, et al. (2008) Proteomic profiling of urine for the detection of colon cancer. Proteome Sci 6: 19-34.
29. Deutsch EW, Mendoza L, Shteynberg D, Farrah T, Lam H, et al. (2010) A guided tour of the Trans-Proteomic Pipeline. Proteomics 10: 1150-1159.
30. Keller A, Eng J, Zhang N, Li XJ, Aebersold R, (2005) A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol 1: 2005 0017.
31. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
32. Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV, (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 278: 4238-4249.
33. Gonzalez EM, Reed CC, Bix G, Fu J, Zhang Y, et al. (2005) BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem 280: 7080-7087.
34. Stewart IB, McDonald MD, Hunt AP, Parker TW, (2008) Physical capacity of rescue personnel in the mining industry. J Occup Med Toxicol 3: 22.
35. Dohm GL, Williams RT, Kasperek GJ, van Rij AM, (1982) Increased excretion of urea and N tau-methylhistidine by rats and humans after a bout of exercise. J Appl Physiol 52: 27-33.
36. Viru A, (1987) Mobilisation of structural proteins during exercise. Sports Med 4: 95-128.
37. Suzuki K, Nakaji S, Yamada M, Liu Q, Kurakake S, et al. (2003) Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med Sci Sports Exerc 35: 348-355.
38. Hartmann U, Mester J, (2000) Training and overtraining markers in selected sport events. Med Sci Sports Exerc 32: 209-215.
39. van der Hulst M, (2003) Long workhours and health. Scand J Work Environ Health 29: 171-188.
40. Garde AH, Faber A, Persson R, Hansen AM, Hjortskov N, et al. (2006) Concentrations of cortisol, testosterone and glycosylated haemoglobin (HbA(1c)) among construction workers with 12-h workdays and extended workweeks. Int Arch Occup Environ Health.
41. Fujiwara S, Shinkai S, Kurokawa Y, Watanabe T, (1992) The acute effects of experimental short-term evening and night shifts on human circadian rhythm: the oral temperature, heart rate, serum cortisol and urinary catecholamines levels. Int Arch Occup Environ Health 63: 409-418.
42. Motohashi Y, (1992) Alteration of circadian rhythm in shift-working ambulance personnel. Monitoring of salivary cortisol rhythm. Ergonomics 35: 1331-1340.
43. Cottin V, Deviller P, Tardy F, Cordier JF, (1998) Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo. J Allergy Clin Immunol 101: 116-123.
44. Goto T, Morioka J, Inamura H, Yano M, Kodaira K, et al. (2007) Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity. Allergol Int 56: 433-438.
45. Rosenberg HF, (2008) Eosinophil-derived neurotoxin/RNase 2: connecting the past, the present and the future. Curr Pharm Biotechnol 9: 135-140.
46. Bayne EK, Anderson MJ, Fambrough DM, (1984) Extracellular matrix organization in developing muscle: correlation with acetylcholine receptor aggregates. J Cell Biol 99: 1486-1501.
47. Hassell JR, Robey PG, Barrach HJ, Wilczek J, Rennard SI, et al. (1980) Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci U S A 77: 4494-4498.
48. SundarRaj N, Fite D, Ledbetter S, Chakravarti S, Hassell JR, (1995) Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J Cell Sci 108 (Pt 7): 2663-2672.
49. Clarkson PM, Hubal MJ, (2002) Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 81: S52-69.
50. Ebbeling CB, Clarkson PM, (1989) Exercise-induced muscle damage and adaptation. Sports Med 7: 207-234.
51. Clarkson PM, Tremblay I, (1988) Exercise-induced muscle damage, repair, and adaptation in humans. J Appl Physiol 65: 1-6.
52. Eckstein F, Tieschky M, Faber S, Englmeier KH, Reiser M, (1999) Functional analysis of articular cartilage deformation, recovery, and fluid flow following dynamic exercise in vivo. Anat Embryol (Berl) 200: 419-424.
53. Oda O, Shinzato T, Ohbayashi K, Takai I, Kunimatsu M, et al. (1996) Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin Chim Acta 255: 119-132.
54. Bix G, Fu J, Gonzalez EM, Macro L, Barker A, et al. (2004) Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol 166: 97-109.
55. Chang JW, Kang U, Kim DH, Yi JK, Lee JW, et al. (2008) Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clinical Applications 2: 23-32.
56. Vuadens F, Benay C, Crettaz D, Gallot D, Sapin V, et al. (2003) Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 3: 1521-1525.
57. Cailhier JF, Sirois I, Laplante P, Lepage S, Raymond MA, et al. (2008) Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem 283: 27220-27229.
58. Stevens AL, Wishnok JS, White FM, Grodzinsky AJ, Tannenbaum SR, (2009) Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repair. Mol Cell Proteomics 8: 1475-1489.
59. Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, et al. (1990) Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 49: 676-681.
60. Liu J, Sukhova GK, Yang JT, Sun J, Ma L, et al. (2006) Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 184: 302-311.
61. Sorichter S, Puschendorf B, Mair J, (1999) Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury. Exerc Immunol Rev 5: 5-21.
62. Gu JW, Gadonski G, Wang J, Makey I, Adair TH, (2004) Exercise increases endostatin in circulation of healthy volunteers. BMC Physiol 4: 2.
63. Gierach GL, Chang SC, Brinton LA, Lacey JV Jr, Hollenbeck AR, et al. (2009) Physical activity, sedentary behavior, and endometrial cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer 124: 2139-2147.
64. Courneya KS, (2009) Physical activity in cancer survivors: a field in motion. Psychooncology 18: 337-342.
65. Hamer M, Stamatakis E, Saxton JM, (2009) The impact of physical activity on all-cause mortality in men and women after a cancer diagnosis. Cancer Causes Control 20: 225-231.
66. Nyberg P, Xie L, Sugimoto H, Colorado P, Sund M, et al. (2008) Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor. Exp Cell Res 314: 3292-3305.
67. Chung IS, Son YI, Ko YJ, Baek CH, Cho JK, et al. (2008) Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model. Oral Oncol 44: 1118-1126.
68. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, et al. (2003) Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3: 589-601.
69. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, et al. (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A 100: 4766-4771.